Neuroene Therapeutics

Neuroene Therapeutics is a startup biotechnology company that has developed a vitamin K-based treatment for neurological disorders such as epilepsy. Our long-term goal is to develop our mitochondrial modulator drug discovery platform to identify clinical candidates for potential mitochondrial dysfunction-related diseases. Neuroene Therapeutics' portfolio includes issued and pending patents covering hundreds of analogs aimed at treating various disease indications and corresponding methods.